Ethological and temporal analyses of anxiety-like behavior: The elevated plus-maze model 20 years on

被引:733
作者
Carobrez, AP [1 ]
Bertoglio, LJ
机构
[1] Univ Fed Santa Catarina, Dept Farmacol, CCB, BR-88049900 Florianopolis, SC, Brazil
[2] Univ Sao Paulo, Dept Farmacol, Fac Med, BR-14040900 Ribeirao Preto, SP, Brazil
基金
巴西圣保罗研究基金会;
关键词
anxiety; animal models; risk assessment; min-by-min scoring; test/retest protocol;
D O I
10.1016/j.neubiorev.2005.04.017
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
As well as being considered a reliable measurement instrument of animal anxiety-like behavior, the elevated plus-maze (EPM) is also used as a post-hoc test to evaluate emotionality in genetically modified rodents. The present review considers factors which may further improve the validity (predictive/face/construct) of the EPM model: (1) the importance of measuring defensive patterns of response such as risk assessment in addition to traditional measures such as open arm time; (2) other methodological refinements such as min-by-min scoring and use of a test/retest protocol-, and (3) the identification and control of major sources of variability in this test. To estimate whether current use of the EPM by researchers takes the above factor into account, a survey of the recent literature was conducted. Results showed that the majority of studies have not yet assimilated these important considerations into their use of the EPM. For example, although risk assessment measures may be more sensitive to anxiety modulating drugs than traditional measures, only a quarter of studies have adopted them. It is hoped that this review can provide insights into the optimal use of the EPM, a simple task that can be very complex in terms of behavioral analysis. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1193 / 1205
页数:13
相关论文
共 152 条
[71]  
Gorman JM, 2003, J CLIN PSYCHIAT, V64, P28
[72]  
GRAY AJ, 2000, NEUROPSYCHOLOGY ANXI, P72
[73]  
Green S., 1991, BEHAV MODELS PSYCHOP
[74]   SOME CRITICAL DETERMINANTS OF THE BEHAVIOR OF RATS IN THE ELEVATED PLUS-MAZE [J].
GRIEBEL, G ;
MOREAU, JL ;
JENCK, F ;
MARTIN, JR ;
MISSLIN, R .
BEHAVIOURAL PROCESSES, 1993, 29 (1-2) :37-47
[75]   Risk assessment behaviour: Evaluation of utility in the study of 5-HT-related drugs in the rat elevated plus-maze test [J].
Griebel, G ;
Rodgers, RJ ;
Perrault, G ;
Sanger, DJ .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1997, 57 (04) :817-827
[76]   Is there a future for neuropeptide receptor ligands in the treatment of anxiety disorders? [J].
Griebel, G .
PHARMACOLOGY & THERAPEUTICS, 1999, 82 (01) :1-61
[77]   5HT DRUGS IN ANIMAL-MODELS OF ANXIETY [J].
HANDLEY, SL ;
MCBLANE, JW .
PSYCHOPHARMACOLOGY, 1993, 112 (01) :13-20
[78]   EFFECTS OF ALPHA-ADRENOCEPTOR AGONISTS AND ANTAGONISTS IN A MAZE-EXPLORATION MODEL OF FEAR-MOTIVATED BEHAVIOR [J].
HANDLEY, SL ;
MITHANI, S .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1984, 327 (01) :1-5
[79]   Influence of prior experience on mice behavior using the four-plate test [J].
Hascoet, M ;
Bourin, M ;
DuTertre, AC .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1997, 58 (04) :1131-1138
[80]   A review of the validity and variability of the elevated plus-maze as an animal model of anxiety [J].
Hogg, S .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1996, 54 (01) :21-30